Defining the Role and Responsibilities of the Oral Anticancer Medication Nurse Navigator.
Defining the Role and Responsibilities of the Oral Anticancer Medication Nurse Navigator. Ruim
Defining the Role and Responsibilities of the Oral Anticancer Medication Nurse Navigator. Regular
Defining the Role and Responsibilities of the Oral Anticancer Medication Nurse Navigator. Bom
Defining the Role and Responsibilities of the Oral Anticancer Medication Nurse Navigator. Excelente
Defining the Role and Responsibilities of the Oral Anticancer Medication Nurse Navigator. N/D
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial. Ruim
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial. Regular
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial. Bom
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial. Excelente
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial. N/D
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Ruim
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Regular
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Bom
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Excelente
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. N/D
Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial.
Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial. Ruim
Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial. Regular
Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial. Bom
Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial. Excelente
Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial. N/D
Evaluation of knowledge in oncology about the care of transgender people: A scoping review.
Evaluation of knowledge in oncology about the care of transgender people: A scoping review. Ruim
Evaluation of knowledge in oncology about the care of transgender people: A scoping review. Regular
Evaluation of knowledge in oncology about the care of transgender people: A scoping review. Bom
Evaluation of knowledge in oncology about the care of transgender people: A scoping review. Excelente
Evaluation of knowledge in oncology about the care of transgender people: A scoping review. N/D
Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center.
Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center. Ruim
Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center. Regular
Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center. Bom
Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center. Excelente
Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center. N/D
Health literacy in cancer care: A systematic review.
Health literacy in cancer care: A systematic review. Ruim
Health literacy in cancer care: A systematic review. Regular
Health literacy in cancer care: A systematic review. Bom
Health literacy in cancer care: A systematic review. Excelente
Health literacy in cancer care: A systematic review. N/D
Health-related quality of life the first year after a prostate cancer diagnosis a systematic review.
Health-related quality of life the first year after a prostate cancer diagnosis a systematic review. Ruim
Health-related quality of life the first year after a prostate cancer diagnosis a systematic review. Regular
Health-related quality of life the first year after a prostate cancer diagnosis a systematic review. Bom
Health-related quality of life the first year after a prostate cancer diagnosis a systematic review. Excelente
Health-related quality of life the first year after a prostate cancer diagnosis a systematic review. N/D
The Effects of WeChat-Based Teach-Back Health Education on Patients With Advanced Cancer Pain.
The Effects of WeChat-Based Teach-Back Health Education on Patients With Advanced Cancer Pain. Ruim
The Effects of WeChat-Based Teach-Back Health Education on Patients With Advanced Cancer Pain. Regular
The Effects of WeChat-Based Teach-Back Health Education on Patients With Advanced Cancer Pain. Bom
The Effects of WeChat-Based Teach-Back Health Education on Patients With Advanced Cancer Pain. Excelente
The Effects of WeChat-Based Teach-Back Health Education on Patients With Advanced Cancer Pain. N/D
The application and use of artificial intelligence in cancer nursing: A systematic review.
The application and use of artificial intelligence in cancer nursing: A systematic review. Ruim
The application and use of artificial intelligence in cancer nursing: A systematic review. Regular
The application and use of artificial intelligence in cancer nursing: A systematic review. Bom
The application and use of artificial intelligence in cancer nursing: A systematic review. Excelente
The application and use of artificial intelligence in cancer nursing: A systematic review. N/D